Diagnostic issues and treatment of cryptogenic or symptomatic generalized epilepsies

Yoko Ohtsuka, Harumi Yoshinaga, Katsuhiro Kobayashi, Tatsuya Ogino, Makio Oka, Minako Ito

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

To clarify the diagnostic issues and treatment of patients with cryptogenic or symptomatic generalized epilepsies, not including West syndrome (WS), we investigated electroclinical change during the clinical course, and treatment effects in these patients. The selection criteria were minor generalized seizures as their main seizure type and diffuse epileptic discharges as their main EEG findings. Regarding EEG, we included EEGs that predominantly displayed multifocal spike-waves because of the inclusion of severe epilepsy with multiple independent spike foci (SE-MISF). We divided the subjects into two groups according to their main seizure types: Group A (54 patients) with brief tonic seizures and Group B (24 patients) with myoclonic seizures and/or atypical absences. The main epileptic syndromes were considered to be Lennox-Gastaut syndrome and SE-MISF in Group A, and epilepsy with myoclonic-astatic seizures in Group B. A history of WS was often seen in Group A, but it was exceptional in Group B. During the clinical course, seizure types did not basically change in Group A. EEG patterns were changeable in both groups. Although there was some overlap in electroclinical manifestations among epileptic syndromes, a transition between the two groups was not seen. High-dose valproate and ethosuximide were the most effective in Groups A and B, respectively. Long-term prognosis was significantly more favorable in Group B than in Group A.

Original languageEnglish
JournalEpilepsy Research
Volume70
Issue numberSUPPL.1
DOIs
Publication statusPublished - Aug 2006

Fingerprint

Generalized Epilepsy
Seizures
Electroencephalography
Infantile Spasms
Epilepsy
Therapeutics
Ethosuximide
Myoclonic Epilepsy
Valproic Acid
Focus Groups
Patient Selection

Keywords

  • Epilepsy with myoclonic-astatic seizures
  • Epileptic spasms
  • Lennox-Gastaut syndrome
  • Prognosis
  • Treatment.
  • West syndrome

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Pediatrics, Perinatology, and Child Health

Cite this

Diagnostic issues and treatment of cryptogenic or symptomatic generalized epilepsies. / Ohtsuka, Yoko; Yoshinaga, Harumi; Kobayashi, Katsuhiro; Ogino, Tatsuya; Oka, Makio; Ito, Minako.

In: Epilepsy Research, Vol. 70, No. SUPPL.1, 08.2006.

Research output: Contribution to journalArticle

Ohtsuka, Yoko ; Yoshinaga, Harumi ; Kobayashi, Katsuhiro ; Ogino, Tatsuya ; Oka, Makio ; Ito, Minako. / Diagnostic issues and treatment of cryptogenic or symptomatic generalized epilepsies. In: Epilepsy Research. 2006 ; Vol. 70, No. SUPPL.1.
@article{85247940e3854fc9ba0f846bf5e6312a,
title = "Diagnostic issues and treatment of cryptogenic or symptomatic generalized epilepsies",
abstract = "To clarify the diagnostic issues and treatment of patients with cryptogenic or symptomatic generalized epilepsies, not including West syndrome (WS), we investigated electroclinical change during the clinical course, and treatment effects in these patients. The selection criteria were minor generalized seizures as their main seizure type and diffuse epileptic discharges as their main EEG findings. Regarding EEG, we included EEGs that predominantly displayed multifocal spike-waves because of the inclusion of severe epilepsy with multiple independent spike foci (SE-MISF). We divided the subjects into two groups according to their main seizure types: Group A (54 patients) with brief tonic seizures and Group B (24 patients) with myoclonic seizures and/or atypical absences. The main epileptic syndromes were considered to be Lennox-Gastaut syndrome and SE-MISF in Group A, and epilepsy with myoclonic-astatic seizures in Group B. A history of WS was often seen in Group A, but it was exceptional in Group B. During the clinical course, seizure types did not basically change in Group A. EEG patterns were changeable in both groups. Although there was some overlap in electroclinical manifestations among epileptic syndromes, a transition between the two groups was not seen. High-dose valproate and ethosuximide were the most effective in Groups A and B, respectively. Long-term prognosis was significantly more favorable in Group B than in Group A.",
keywords = "Epilepsy with myoclonic-astatic seizures, Epileptic spasms, Lennox-Gastaut syndrome, Prognosis, Treatment., West syndrome",
author = "Yoko Ohtsuka and Harumi Yoshinaga and Katsuhiro Kobayashi and Tatsuya Ogino and Makio Oka and Minako Ito",
year = "2006",
month = "8",
doi = "10.1016/j.eplepsyres.2005.11.024",
language = "English",
volume = "70",
journal = "Epilepsy Research",
issn = "0920-1211",
publisher = "Elsevier",
number = "SUPPL.1",

}

TY - JOUR

T1 - Diagnostic issues and treatment of cryptogenic or symptomatic generalized epilepsies

AU - Ohtsuka, Yoko

AU - Yoshinaga, Harumi

AU - Kobayashi, Katsuhiro

AU - Ogino, Tatsuya

AU - Oka, Makio

AU - Ito, Minako

PY - 2006/8

Y1 - 2006/8

N2 - To clarify the diagnostic issues and treatment of patients with cryptogenic or symptomatic generalized epilepsies, not including West syndrome (WS), we investigated electroclinical change during the clinical course, and treatment effects in these patients. The selection criteria were minor generalized seizures as their main seizure type and diffuse epileptic discharges as their main EEG findings. Regarding EEG, we included EEGs that predominantly displayed multifocal spike-waves because of the inclusion of severe epilepsy with multiple independent spike foci (SE-MISF). We divided the subjects into two groups according to their main seizure types: Group A (54 patients) with brief tonic seizures and Group B (24 patients) with myoclonic seizures and/or atypical absences. The main epileptic syndromes were considered to be Lennox-Gastaut syndrome and SE-MISF in Group A, and epilepsy with myoclonic-astatic seizures in Group B. A history of WS was often seen in Group A, but it was exceptional in Group B. During the clinical course, seizure types did not basically change in Group A. EEG patterns were changeable in both groups. Although there was some overlap in electroclinical manifestations among epileptic syndromes, a transition between the two groups was not seen. High-dose valproate and ethosuximide were the most effective in Groups A and B, respectively. Long-term prognosis was significantly more favorable in Group B than in Group A.

AB - To clarify the diagnostic issues and treatment of patients with cryptogenic or symptomatic generalized epilepsies, not including West syndrome (WS), we investigated electroclinical change during the clinical course, and treatment effects in these patients. The selection criteria were minor generalized seizures as their main seizure type and diffuse epileptic discharges as their main EEG findings. Regarding EEG, we included EEGs that predominantly displayed multifocal spike-waves because of the inclusion of severe epilepsy with multiple independent spike foci (SE-MISF). We divided the subjects into two groups according to their main seizure types: Group A (54 patients) with brief tonic seizures and Group B (24 patients) with myoclonic seizures and/or atypical absences. The main epileptic syndromes were considered to be Lennox-Gastaut syndrome and SE-MISF in Group A, and epilepsy with myoclonic-astatic seizures in Group B. A history of WS was often seen in Group A, but it was exceptional in Group B. During the clinical course, seizure types did not basically change in Group A. EEG patterns were changeable in both groups. Although there was some overlap in electroclinical manifestations among epileptic syndromes, a transition between the two groups was not seen. High-dose valproate and ethosuximide were the most effective in Groups A and B, respectively. Long-term prognosis was significantly more favorable in Group B than in Group A.

KW - Epilepsy with myoclonic-astatic seizures

KW - Epileptic spasms

KW - Lennox-Gastaut syndrome

KW - Prognosis

KW - Treatment.

KW - West syndrome

UR - http://www.scopus.com/inward/record.url?scp=33750591513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750591513&partnerID=8YFLogxK

U2 - 10.1016/j.eplepsyres.2005.11.024

DO - 10.1016/j.eplepsyres.2005.11.024

M3 - Article

C2 - 16815681

AN - SCOPUS:33750591513

VL - 70

JO - Epilepsy Research

JF - Epilepsy Research

SN - 0920-1211

IS - SUPPL.1

ER -